Plain-English translation of NCT04221542 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new medicine called to see if it can help men with advanced prostate cancer that has stopped responding to standard hormone treatments. Researchers want to find the right dose of the medication, understand how safe it is, and get an early sense of whether it helps shrink tumors. The medication may be given on its own or combined with other prostate cancer drugs you may already be taking.
Men with advanced prostate cancer often develop resistance to hormone therapy, meaning standard treatments stop working. This trial is exploring whether this new medication offers another effective option for patients who have exhausted other available treatments.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic regularly to receive as an intravenous infusion (through a needle in your vein). Between infusions, you would have blood tests and scans to monitor your cancer and check for any side effects. Depending on which part of the study you join, you may receive the medication alone or in combination with another prostate cancer drug you may already be taking. Your doctors will carefully track how your body responds to the treatment and adjust the dose if needed.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States